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Abstract: 
Objective: To evaluate the thyroid dysfunction in patients of nephrotic syndrome presenting at BVH Bahawalpur. 
Material and methods: In this cross-sectional study total 39 patients of nephrotic syndrome having age >18 years, 
both male or female were selected from Department of Pathology, Quaid-e-Azam Medical College Bahawalpur from 
October 2018 to April 2019.  Thyroid dysfunction was assessed in selected patients. 
Results: Thirty-nine patients presented with newly diagnosed NS. The mean age of the study population was 
34.89±9.14 years and was not significantly different from that of controls (n=39). When compared to the age and sex 
matched control group, patients with NS had significantly higher TSH and significantly lower TT4, TT3, FT3 and FT4 
Conclusion: The study confirms that significant number of adult patients with NS have abnormalities in thyroid 
function tests. Most of these abnormalities improve with remission of NS. Anti-TPO antibodies tend to be more 
common in adult NS patients than control group and those with elevated anti-TPO are more likely to progress to overt 
hypothyroidism. Hence, all patients with NS who have elevated TSH should be evaluated for anti-TPO and those with 
elevated anti-TPO should be closely followed-up or replaced with LT4. 
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INTRODUCTION: 
Nephrotic syndrome (NS) is one of the most common 
glomerular diseases and is defined by edema, 
substantial proteinuria (>3.5 g/24 hours), 
hypoalbuminemia (<30 g/L) and hyperlipidemia.  It is 
a common cause of massive proteinuria and is 
associated with loss of multiple binding proteins 
(thyroid binding globulin (TBG), corticosteroid 
binding globulin and vitamin D binding globulin).1,2 
Urinary loss of thyroid binding globulin is 
accompanied with loss of thyroxine (T4) and 
triiodothyronine (T3).3-6 This leads to decrease in total 
serum thyroxine (TT4) and total serum 
triiodothyronine (TT4) concentrations and increases 
the demand on thyroid gland to produce more T4. This 
increased demand is reflected by increase in the 
elevation of thyroid stimulating hormone (TSH), 
although not always above the upper limit of normal.4,5  
 
Many studies have reported thyroid dysfunction in 
children with NS.4-7 In children, association of thyroid 
dysfunction with NS may help to identify the latter 
condition at an earlier stage. Elevation of TSH in new-
born screening programs often leads to diagnosis of 
congenital NS.8,9 However, there is limited data on 
thyroid abnormalities in adults with NS. More 
importantly, the natural history of thyroid 
abnormalities in adult patients with NS is not well 
studied. It has been documented that abnormalities in 
thyroid functions could be normalized by LT4 
replacement. On the other hand, few studies have 
concluded that thyroid abnormalities are transient and 
does not require replacement with LT4.4,11 
 
Hence, it is not clear whether patients with NS with 
subclinical hypothyroidism should receive 
replacement with L-thyroxine. It would be important 
to know the course of thyroid functions in adult 
patients with NS and identify any predictors of 
persistence of hypothyroidism in them. Hence, we 
have studied the thyroid function abnormalities and 
predictors of persistence of thyroid abnormalities in 
adults with NS. 
 
Operational definition: 
Nephrotic syndrome: Nephrotic syndrome was 
defined as 24-h urinary protein excretion >3.5 
g/1.73m2 or spot urinary protein creatinine ratio >2.0.  
 
MATERIAL AND METHODS: 
In this cross-sectional study total 39 patients of 
nephrotic syndrome having age >18 years, both male 
or female were selected from Department of 
Pathology, Quaid-e-Azam Medical College 
Bahawalpur from October 2018 to April 2019.  The 
study was approved by institutional ethics committee 
and a written informed consent was obtained by all 
participants.  Patients with acute sickness, pregnancy, 
lactation, diabetes mellitus and previously diagnosed 
patients with hypothyroidism were excluded from the 
study.  Age and sex matched healthy volunteers 
constituted the control group. 
 
At diagnosis of NS, all participants were subjected for 
serum total protein, albumin and globulin, 24-h 
urinary protein excretion, spot urinary protein 
creatinine ratio, thyroid function tests including TSH, 
TT4, TT3, FT3, FT4 and anti-thioperoxides antibody 
(anti-TPO) level. Additional investigations such as 
renal biopsy, serum complement 3, antinuclear 
antibody, HBsAg, anti HCV and anti-HIV etc were 
performed as per the standard protocol at our 
institution to evaluate an adult with new onset NS.  
 
All patients received treatment with 
immunosuppressive drugs as per the standard 
protocols. Patients were followed up every 1-3 
monthly with spot urinary protein creatinine ratio, 
serum creatinine and serum albumin and 2-3 monthly 
with thyroid function tests.  
 
Normal reference range for TSH, TT4, TT3, FT3, FT4 
and anti TPO were 0.4-4.2μIU/ml, 5.5-11.0 μg/dl, 
0.94-180 ng/ml, 2.5-3.9 pg/ml, 0.61-1.12 ng/dl and 9 
IU/ml.  
 
All the collected was entered in SPSS version 18 and 
analyzed.  Mean and SD was calculated for numerical 
data and frequency and percentage was calculated for 
categorical data.   
 
RESULTS: 
Thirty-nine patients presented with newly diagnosed 
NS. The mean age of the study population was 
34.89±9.14 years and was not significantly different 
from that of controls (n=39).  
When compared to the age and sex matched control 
group, patients with NS had significantly higher TSH 
and significantly lower TT4, TT3, FT3 and FT4 (Table 
1). In NS group, sixteen (41.02%) patients had normal 
TSH (0.4-4.2 μIU/ml), four (10.25%) had more than 
10 μIU/ml whereas the rest (19, 48.71%) had TSH 
between 4.2 and 10 μIU/ml. Fourteen (35.89%) 
patients had a low TT4 and nine (23.07%) had low 
TT3 whereas FT3 was low in four (10.25%) and FT4 
was low in three (7.6%) at presentation. In healthy 
volunteer group, none of the patients had abnormal 
thyroid function tests. Among NS group, eight patients 
had elevated anti-TPO whereas only two subjects in 
the control group had positive anti-TPO (p=0.3). None 
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of the patients had TSH >15 μIU/ml and none were 
replaced with thyroxine.  
 
Patients with NS were followed-up over a period of 
18.3±3.4 months. Eighteen patients had remission of 
NS at last follow-up whereas the rest had persistence 
of NS. At last follow-up, TSH was significantly lower 
whereas TT4, TT3, FT3 and FT4 were significantly 
higher when compared to that at diagnosis of NS. 
There was significant reduction in serum creatinine 
and spot urinary protein to creatinine ratio and 
significant increase in serum albumin in patients with 
remission of NS (Table 2). 
 
Table 1: Comparison of thyroid function tests between patients with nephrotic syndrome at diagnosis and 
healthy volunteers. 
Variable Nephrotic syndrome Controls P value 
Thyroid stimulating hormone (μIU/ml) 7.03±4.21 2.58±0.98 <0.001 
Total triiodothyronine (ng/dl) 97.46±10.89 141.28±18.63 <0.001 
Total thyroxine (μg/dl) 7.37±1.26 10.09±1.42 <0.001 
Free triiodothyronine (pg/ml) 2.69±0.32 3.29±0.36 <0.001 
Free thyroxine (ng/dl) 0.85±0.21 1.07±0.12 <0.001 
Age (years) 34.89±9.14 34.97±8.31 0.9 
Male: Female 18:21 19:20 0.5 
 
Table 2: Comparison of patient characteristics at diagnosis of nephrotic syndrome and at last follow-up. 
Variable At diagnosis of nephrotic syndrome At last follow-up P value 
Total triiodothyronine (ng/dl) 97.46±10.89 125.33±15.62 <0.0001 
Total thyroxine (μg/dl) 7.37±1.26 8.54±1.93 0.002 
Free triiodothyronine (pg/ml) 2.69±0.32 2.89±0.37 0.01 
Free thyroxine (ng/dl) 0.85±0.21 0.94±0.25 0.01 
Thyroid stimulating hormone (μIU/ml) 7.03±4.21 4.34±3.68 0.003 
Spot urinary protein/creatinine 7.25±3.23 3.38±3.12 <0.0001 
Serum albumin (g/dl) 2.02±0.48 3.11±0.8 <0.0001 
Serum creatinine (mg/dl) 1.61±0.38 1.18±0.41 <0.0001 
Serum sodium (mEq/l) 133.66±8.27 135.11±7.72 0.42 
 
DISCUSSION: 
This study reports significantly lower concentration of 
serum TT4, TT3, FT3 and FT4 and significantly 
higher concentration of serum TSH in patients with 
NS when compared with age and sex matched healthy 
volunteers. Previous studies have demonstrated 
similar findings.4-7 Studies have also documented 
significant reduction in serum TBG levels.12 Decrease 
in concentration of serum TT4, TT3, FT3, FT4 and 
TBG levels in patients with NS is due to excessive 
urinary loss of these substances.3-6  
 
Urinary loss of serum T4, T3 and TBG levels in-turn 
lead to significant decrease in serum TT3 and TT4 and 
demands increased production of T4 from the thyroid 
gland to compensate for the urinary loss of T4 and 
T3.4,5 This in turn increases serum TSH level. In 
milder cases, increase in TSH compensates to 
maintain serum FT3 and FT4 level. However, in 
severe urinary T4 loss, thyroid gland may not be able 
to meet for the increasing demand and FT4 level may 
fall below the normal range. In agreement with this, 
58.97% of our patients had elevated TSH whereas only 
7.6% of patients had low FT4. However, a larger 
number of patients demonstrate low serum TT4 level. 
Compared to 7.2% patients who had lower FT4, higher 
number (35.89%) of patients had low serum TT4, 
which is due to concomitant loss of TBG.  
 
The study also evaluated the thyroid functions at last 
follow-up in all patients and demonstrated that the 
abnormalities in thyroid function improved in most of 
the patients with remission of NS. Similar effect of 
remission of NS on thyroid functions has been 
reported previously.3-5,10 Improvement in thyroid 
functions of NS patients has also been documented 
with bilateral nephrectomy which provides a cure for 
proteinuria and prevents loss of TBG and T4 in urine.13  
Anti-TPO antibodies tended to be more common in 
NS patients than in control group. It may be a 
reflection of underlying autoimmune etiology of NS in 
these patients. Coexistence of autoimmune 
hypothyroidism has been described previously with 
various histological types of nephrotic syndrome, 
especially with membranous nephropathy.14-18 In our 
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study, four of 15 patients with membranous 
nephropathy had elevated anti-TPO antibodies.  
 
Among patients with remission elevated anti-TPO 
antibody was associated with persistence of 
hypothyroidism at last follow-up and these patients 
were initiated on LT4 replacement. Higher rate of 
progression to overt hypothyroidism in patients with 
positive anti microsomal antibodies has been proven 
previously.19 Hence, patients with elevated anti-TPO 
should be closely followed-up for progression of 
hypothyroidism or initiated on LT4 replacement.  
 
CONCLUSION: 
The study confirms that significant number of adult 
patients with NS have abnormalities in thyroid 
function tests. Most of these abnormalities improve 
with remission of NS. Anti-TPO antibodies tend to be 
more common in adult NS patients than control group 
and those with elevated anti-TPO are more likely to 
progress to overt hypothyroidism. Hence, all patients 
with NS who have elevated TSH should be evaluated 
for anti-TPO and those with elevated anti-TPO should 
be closely followed-up or replaced with LT4.  
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